Cerenome (CNSY) vs Tenon Medical (TNON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Cerenome (CNSY) has outperformed Tenon Medical (TNON) over the past year, losing 89.3% versus a loss of 91.8%. Cerenome is the larger company by market cap ($14.6 million vs $9.2 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNSY | TNON |
|---|---|---|
| Share price | $1.93 | $3.41 |
| Market cap | $14.65M | $9.17M |
| 1-day change | +7.82% | -0.87% |
| YTD return | -84.86% | -89.77% |
| 1-year return | -89.28% | -91.81% |
| 5-year return | -99.71% | — |
| EPS (TTM) | $-3.36 | $-44.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.00 | $50.40 |
| 52-week low | $1.49 | $2.40 |
| Distance from 52-week high | -89.84% | -93.23% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +1337.82% | +1201.47% |
| Average volume | 121.94K | 6.40M |
| Shares outstanding | 7.59M | 2.69M |
| Employees | 28 | 26 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cerenome
CNSY stock →Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers.
Health Care · Medical/Dental Instruments · 28 employees
About Tenon Medical
TNON stock →Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain.
Health Care · Medical/Dental Instruments · 26 employees
CNSY vs TNON FAQ
Which is bigger, Cerenome or Tenon Medical?
Cerenome (CNSY) is larger, with a market capitalization of $14.65M compared with $9.17M for Tenon Medical (TNON).
Which stock has performed better over the past year, CNSY or TNON?
CNSY returned -89.28% over the past 12 months, compared with -91.81% for TNON (price return, excluding dividends). Past performance does not predict future results.
Are Cerenome and Tenon Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.